Collegium Pharmaceutical, Inc. (COLL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
100 Technology Center Drive
Stoughton, MA 02072
United States of America (the)
Phone
781 713 3699
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
357
First IPO Date
May 07, 2015
| Name | Title | Pay | Year Born |
| Vikram Karnani | President, Chief Executive Officer & Director | 1.72M | 1975 |
| David Dieter | Executive Vice President, General Counsel & Corporate Secretary | 782,283 | 1964 |
| Thomas Smith FAAFP | Executive Vice President & Chief Medical Officer | 825,694 | 1961 |
| Scott Dreyer | Executive Vice President & Chief Commercial Officer | 880,739 | 1972 |
| Colleen Tupper | Executive Vice President & Chief Financial Officer | 1.03M | 1976 |
| Dean J. Patras | Chief People Officer | 0 | N/A |
| Ian Karp | Head of Investor Relations | 0 | N/A |
| Scott Sudduth | EVP & Head of Technical Operations | 0 | N/A |
| Jane Gonnerman | Executive Vice President of Strategy & Corporate Development | 0 | N/A |
| Jessica Cotrone | Senior Vice President of Communications & Corporate Affairs | 0 | N/A |
Collegium Pharmaceutical, Inc. (COLL) is a specialized pharmaceutical firm dedicated to the development and marketing of medications for pain management. Its diverse product lineup features significant therapies aimed at addressing various pain conditions. A prominent offering is Xtampza ER, an extended-release, oral formulation of oxycodone, specifically engineered with properties to deter abuse. This particular drug is prescribed for patients experiencing severe, persistent pain that necessitates daily, continuous, long-term opioid therapy. The company's portfolio also encompasses Nucynta ER and Nucynta IR, which are extended-release and immediate-release versions of tapentadol, respectively. Founded in 2002, the enterprise initially operated under the name Collegium Pharmaceuticals, Inc., before officially adopting its current identity as Collegium Pharmaceutical, Inc. in October 2003. The company's corporate headquarters are situated in Stoughton, Massachusetts.